Verge Genomics
Leadership Approach Pipeline Partnerships News Careers
LeadershipApproachPipelinePartnershipsNewsCareers
Verge Genomics

Blog

Press-release-hero-image.jpg
How Radical Candor, Mindfulness, Compassion, and Authenticity Help Drive Verge’s Scientific Innovation.
Rob MaguireNovember 13, 2023
Why Machine Learning and Artificial Intelligence Are Transforming Pharmaceutical R&D Collaborations
Rob MaguireSeptember 12, 2023
At ENCALS, Commitment to Understanding the Cause of ALS and Developing Effective Treatments
Rob MaguireJuly 18, 2023
The FDA Made History in ALS: What’s Next?
Rob MaguireMay 4, 2023
Paper in CELL Further Validates PIKfyve as Promising Therapeutic Target
Rob MaguireFebruary 22, 2023
First, We Need to Generate the Right Data. Then AI Will Shine
Rob MaguireFebruary 9, 2023
Deeper than validation: How Verge Genomics establishes causality for its drug targets
Rob MaguireJune 14, 2022
People-Focused Drug Development: Meeting the Challenge
Rob MaguireApril 27, 2022
An All-In-Human Approach to Neurodegenerative Diseases
Rob MaguireMarch 16, 2022
  • Home
  • Leadership
  • Approach
  • Pipeline
  • Accessibility
  • Partnerships
  • News
  • Careers
  • Privacy
Verge Genomics Logo

131 Oyster Point Blvd
Suite 300
South San Francisco
CA 94080

  • LinkedIn icon graphic
    X logo icon graphic
  • info@vergegenomics.com
Copyright 2023